maker, Ozempic

Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs

Posted on by Zonia Catt
Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs
24
Oct

Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight loss and diabetes medications.Read more…
Read More

Leave a Reply

You were not leaving your cart just like that, right?

Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)

Want to receive personalized offers?

Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊

Maybe later